Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|December 15, 2007
Endoscopic transpapillary approach to the gallbladder for diagnosing gallbladder cancerS Matsubara, T Arizumi, O Togawa, et al.Clinical Nephrology|April 1, 2010
Laboratory and imaging features of kidney involvement in autoimmune pancreatitis: incidence, correlation, and steroid therapy responseH Nishi, Y Shibagaki, K Hirano, et al.Internal Medicine Journal|January 18, 2006
High-rate pulmonary involvement in autoimmune pancreatitisK Hirano, T Kawabe, Y Komatsu, et al.British Journal of Cancer|May 5, 2012
A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP studyY Nakai, H Isayama, T Sasaki, et al.British Journal of Cancer|March 20, 2014
Prognostic nomogram for nonresectable pancreatic cancer treated with gemcitabine-based chemotherapyT Hamada, Y Nakai, H Yasunaga, et al.Endoscopy|June 29, 2013
Japanese multicenter experience of endoscopic necrosectomy for infected walled-off pancreatic necrosis: The JENIPaN studyI Yasuda, M Nakashima, T Iwai, et al.British Journal of Cancer|October 28, 2010
Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabineY Nakai, H Isayama, H Ijichi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2015
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancerM Ueno, T Okusaka, Y Omuro, et al.British Journal of Cancer|April 17, 2015
Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancerS Ohkawa, T Okusaka, H Isayama, et al.Analytical Chemistry|March 27, 2025
Advanced Computational Techniques for Plasmonic Metasurfaces in the Detection of Neglected Infectious DiseasesFelipe M F Teixeira, Ary V R Portes, Talles E M Marques, et al.Pageof 2